Clinical Trials Logo

Clinical Trial Summary

The aim of the investigators study is to compare in children aged less than 18 months and hospitalized for an acute viral bronchiolitis the efficacy of the HS 3% (Mucoclear®, sterile ampoules of 4 ml) nebulised with a conventional jet-nebulizer (particles diameter of 4-5 µm), or with a jet-nebulizer adapted for infants (particles diameter of 2-2.5 µm), or with a mesh-nebulizer adapted for infants (particles diameter of 2-2.5 µm).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01295398
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact
Status Active, not recruiting
Phase N/A
Start date December 2010
Completion date November 2014

See also
  Status Clinical Trial Phase
Completed NCT01777347 - Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis Phase 3
Not yet recruiting NCT01437956 - KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis N/A
Completed NCT01873144 - High Flow Therapy vs Hypertonic Saline in Bronchiolitis Phase 3
Completed NCT05899894 - NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study N/A
Completed NCT02460614 - Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis N/A
Completed NCT03738501 - Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis N/A
Recruiting NCT03976895 - Prone Position in Acute Bronchiolitis N/A